fluoxetine and phenelzine

fluoxetine has been researched along with phenelzine in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.76)	18.7374
1990's	24 (57.14)	18.2507
2000's	8 (19.05)	29.6817
2010's	8 (19.05)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M	1
Dansette, PM; Fontana, E; Poli, SM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Brady, LS; Gold, PW; Herkenham, M; Lynn, AB; Whitfield, HJ	1
Williams, LS	1
Carrasco, JL; Hollander, E; Liebowitz, MR; Schneier, FR	1
Campeas, R; Fallon, BA; Feerick, J; Gitow, A; Hollander, E; Liebowitz, MR; Saoud, JB; Schneier, FR; Street, L; Welkowitz, LA	1
Boyer, WF; Feighner, JP; Neborsky, RJ; Tyler, DL	1
Frances, H; Khidichian, F	1
Hrdina, PD	1
Davidson, RK; Dilsauer, SC; Hariharen, M	1
Baker, GB; McManus, DJ; Todd, KG	1
Flint, AJ; Rifat, SL	5
Klemfuss, H; Kripke, DF	1
Fallon, BA; Feerick, J; Liebowitz, MR; Marshall, RD; Schneier, FR	1
Beasley, CM; Heiligenstein, JH; Masica, DN; Wheadon, DE; Zerbe, RL	1
Eagles, JM; Parkin, JR	1
Baker, RA; Brady, LS; Herkenham, M	1
Birkett, M; Fechner-Bates, S; Greden, JF; Haskett, RF; Pande, AC	1
Baer, L; Buttolph, ML; Jenike, MA; Minichiello, WE; Rauch, SL	1
Breese, GR; Carson, SW; Duncan, GE; Knapp, DJ	1
Daws, LC; Frazer, A; Lopez, R	1
Golwyn, DH; Sevlie, CP	1
Bustos, SG; Lacerra, C; Martijena, ID; Molina, VA	1
De Montis, MG; Gambarana, C; Scheggi, S; Tagliamonte, A; Tolu, P	1
Berger, I; Gross-Tsur, V; Jaworowski, S	1
Holmes, A; Rodgers, RJ	1
Dwivedi, Y; Pandey, GN; Rizavi, HS	1
Balu, DT; Hoshaw, BA; Lucki, I; Malberg, JE; Rosenzweig-Lipson, S; Schechter, LE	1
García-Fuster, MJ; García-Sevilla, JA	1

Reviews

5 review(s) available for fluoxetine and phenelzine

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Medication therapy for social phobia. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Benzamides; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1994
Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:5 Topics: Adult; Aged; Brain; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Fatal Outcome; Female; Fluoxetine; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Neurologic Examination; Phenelzine; Product Surveillance, Postmarketing; Receptors, Serotonin; Tranylcypromine	1993
Selective mutism: a review of the concept and treatment. The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:12 Topics: Anxiety; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Mutism; Phenelzine; Phobic Disorders; Prevalence; Selective Serotonin Reuptake Inhibitors	2002

Trials

3 trial(s) available for fluoxetine and phenelzine

Article	Year
Fluoxetine versus phenelzine in atypical depression. Biological psychiatry, 1996, Nov-15, Volume: 40, Issue:10 Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Phenelzine; Selective Serotonin Reuptake Inhibitors	1996
Anxious depression in elderly patients. Response to antidepressant treatment. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1997,Spring, Volume: 5, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Phenelzine; Psychiatric Status Rating Scales; Treatment Outcome	1997
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. The American journal of psychiatry, 1997, Volume: 154, Issue:9 Topics: Adult; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Phenelzine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1997

Other Studies

34 other study(ies) available for fluoxetine and phenelzine

Article	Year
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European journal of pharmacology, 1997, Dec-11, Volume: 340, Issue:2-3 Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes	1997
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain research, 1992, Feb-14, Volume: 572, Issue:1-2 Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Dioxanes; Fluoxetine; Idazoxan; Locus Coeruleus; Male; Mineralocorticoids; Paraventricular Hypothalamic Nucleus; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; RNA, Messenger; Tyrosine 3-Monooxygenase	1992
Canadians' obsession with thinness provides full-time work for Alberta psychiatrist. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1992, Oct-15, Volume: 147, Issue:8 Topics: Adolescent; Alberta; Attitude to Health; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Phenelzine; Psychiatry; Psychotherapy, Group; Referral and Consultation; Social Values	1992
Treatment outcome of obsessive compulsive disorder with comorbid social phobia. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:11 Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Phenelzine; Phobic Disorders; Probability; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1992
Treatment of social phobia with drugs other than benzodiazepines. The Journal of clinical psychiatry, 1991, Volume: 52 Suppl Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Humans; Male; Moclobemide; Phenelzine; Phobic Disorders; Placebos	1991
Adverse consequences of fluoxetine-MAOI combination therapy. The Journal of clinical psychiatry, 1990, Volume: 51, Issue:6 Topics: Adult; Akathisia, Drug-Induced; Confusion; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Phenelzine; Tranylcypromine; Tremor	1990
Chronic but not acute antidepressants interfere with serotonin (5-HT1B) receptors. European journal of pharmacology, 1990, Apr-10, Volume: 179, Issue:1-2 Topics: Animals; Antidepressive Agents; Escape Reaction; Fluoxetine; Indoles; Injections, Intraperitoneal; Male; Mice; Phenelzine; Piperazines; Receptors, Serotonin; Time Factors	1990
Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants. European journal of pharmacology, 1987, Jun-19, Volume: 138, Issue:2 Topics: Animals; Antidepressive Agents; Binding, Competitive; Biogenic Amines; Brain; Carrier Proteins; Fluoxetine; In Vitro Techniques; Iprindole; Kinetics; Male; Maprotiline; Nortriptyline; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, Neurotransmitter; Serotonin; Synaptosomes	1987
Desipramine subsensitizes nicotinic mechanism involved in regulating core temperature. Psychiatry research, 1988, Volume: 25, Issue:1 Topics: Amitriptyline; Animals; Body Temperature Regulation; Brain; Desipramine; Fluoxetine; Light; Lithium; Male; Nicotine; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Nicotinic	1988
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cellular and molecular neurobiology, 1995, Volume: 15, Issue:3 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Clomipramine; Desipramine; Flunitrazepam; Fluoxetine; Ketanserin; Male; Maprotiline; Phenelzine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, GABA-A; Receptors, Serotonin; Serotonin Antagonists	1995
A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Phenelzine; Prospective Studies	1994
Antidepressant and depressogenic drugs lack consistent effects on hamster circadian rhythms. Psychiatry research, 1994, Volume: 53, Issue:2 Topics: Animals; Antidepressive Agents; Arousal; Circadian Rhythm; Clonidine; Clorgyline; Cricetinae; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Male; Mesocricetus; Motor Activity; Phenelzine; Propranolol	1994
Practical approaches to the treatment of social phobia. The Journal of clinical psychiatry, 1994, Volume: 55, Issue:8 Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; Comorbidity; Female; Fluoxetine; Humans; Male; Mental Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Prevalence	1994
Blood-letting in bulimia nervosa. The British journal of psychiatry : the journal of mental science, 1993, Volume: 162 Topics: Adult; Bloodletting; Bulimia; Child of Impaired Parents; Combined Modality Therapy; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Personality Development; Phenelzine; Phototherapy; Psychotherapy; Psychotherapy, Group; Students, Medical	1993
Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats. Journal of neuroendocrinology, 1996, Volume: 8, Issue:5 Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Arcuate Nucleus of Hypothalamus; Fluoxetine; Gene Expression; Idazoxan; Image Processing, Computer-Assisted; Imipramine; In Situ Hybridization; Male; Neuropeptide Y; Phenelzine; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors	1996
The effect of sequential antidepressant treatment on geriatric depression. Journal of affective disorders, 1996, Jan-22, Volume: 36, Issue:3-4 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Clinical Protocols; Combined Modality Therapy; Dementia; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Fluoxetine; Humans; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Personality Inventory; Phenelzine; Prospective Studies; Treatment Outcome	1996
Two-year outcome of elderly patients with anxious depression. Psychiatry research, 1997, Jan-15, Volume: 66, Issue:1 Topics: Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Geriatric Psychiatry; Humans; Lithium Carbonate; Male; Middle Aged; Phenelzine; Recurrence; Treatment Outcome	1997
Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2 Topics: Animals; Antidepressive Agents; Corticosterone; Fluoxetine; Imipramine; Male; Phenelzine; Progesterone; Rats; Rats, Sprague-Dawley; Stress, Physiological; Swimming	1998
Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoceptors in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1998, Volume: 19, Issue:4 Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Antidepressive Agents; Avoidance Learning; Desipramine; Fluoxetine; Injections, Intraventricular; Male; Muscarinic Antagonists; Phenelzine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Scopolamine	1998
Fluoxetine versus phenelzine in obsessive-compulsive disorder. The American journal of psychiatry, 1999, Volume: 156, Issue:1 Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Drug Administration Schedule; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Phenelzine; Placebos; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs. Brain research, 1999, Feb-20, Volume: 819, Issue:1-2 Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Avoidance Learning; Conditioning, Classical; Cues; Desipramine; Diazepam; Electroshock; Escape Reaction; Fluoxetine; Male; Odorants; Phenelzine; Rats; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Time Factors	1999
Maintenance treatment for recurrent depression in late life. A four-year outcome study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2000,Spring, Volume: 8, Issue:2 Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Nortriptyline; Phenelzine; Recurrence; Treatment Outcome	2000
Animal models for the study of antidepressant activity. Brain research. Brain research protocols, 2001, Volume: 7, Issue:1 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite; Behavior, Animal; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Escape Reaction; Fluoxetine; Imipramine; Male; Maze Learning; Phenelzine; Rats; Rats, Sprague-Dawley; Reward; Stress, Physiological; Time Factors	2001
Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. European journal of pharmacology, 2003, Jan-17, Volume: 459, Issue:2-3 Topics: Animals; Anxiety; Fluoxetine; Male; Maze Learning; Mice; Phenelzine	2003
Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience, 2006, Volume: 139, Issue:3 Topics: Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Desipramine; Drug Implants; Exons; Fluoxetine; Gene Expression; Male; Phenelzine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic	2006
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain research, 2008, May-23, Volume: 1211 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Central Nervous System; Chlordiazepoxide; Desipramine; Electroshock; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Phenelzine; Rats; Rats, Sprague-Dawley; RNA, Messenger	2008
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration. Psychopharmacology, 2016, Volume: 233, Issue:15-16 Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles	2016